advertisement
Browse by
Biotechnology

No bull here: ImmuCell moves ahead with expansion plans

A Portland-based animal health products manufacturer is moving ahead with expansion plans for production after it closed a public offering of 1.1 million shares to raise $5.3 million to fund the...

TechPlace biotech firm now taking U.S. orders

Swiss biotech company InSphero AG, a supplier of 3D microtissues for drug testing, said it started taking and processing orders with North American customers on Feb. 1 through its U.S. subsidiary at...

Private-sector group forms to grow three industries

Peter Van Allen |

Maine's agriculture, aquaculture and biopharma industries will be the focus of a nonpartisan effort to create thousands of high-paying jobs over the next decade.

Bigelow Lab grabs $6.2M in awards

The Harold Alfond Foundation has awarded $3.1 million to Bigelow Laboratory for Ocean Sciences to build a 32-bed student and visiting scientist residence on its East Boothbay Campus. An anonymous...

Jackson Lab to get $1M gift from health pioneer

The Jackson Laboratory said it will get a planned $1 million gift from Dennis J. Paustenbach, a pioneer in the health and environmental risk assessment industry, to support its cancer and immunology...

Jackson Lab awarded $1.6 million grant for genetics education

The Jackson Laboratory in Bar Harbor has been awarded a four-year, $1.6 million grant from the Howard Hughes Medical Institute to expand its course offerings in mammalian genetics, genomics and...

Jackson Lab spinout raises $5.5 million in Series A financing

Cyteir Therapeutics Inc., a biopharmaceutical startup spun out from The Jackson Laboratory three years ago, has raised $5.5 million in funding for its research to combat cancer.

IDEXX founder David Shaw on his investment philosophy

Lori Valigra |

Toward the end of his time at IDEXX Laboratories Inc., founder David Shaw set up Black Point Group LLC as a vehicle to invest in other companies. That was in 2000. Now, the investment firm has a...

Idexx Q3 earnings exceed expectations

Westbrook-based Idexx Laboratories Inc. (NASDAQ: IDXX) on Wednesday reported third-quarter profits of $44.2 million, exceeding Wall Street expectations.

Benjamin Shaw's Vets First Choice bites into traditional distribution

Lori Valigra |

Benjamin Shaw focuses calmly and steadily on his visitor during a recent interview at his Portland office. The only "tell" that there's intensity behind his quiet demeanor is...

ADVERTISEMENTS